Biblio

Export 1532 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is H  [Clear All Filters]
2019
K. E. Osborn, Alverio, J. M., Dumitrescu, L., Pechman, K. R., Gifford, K. A., Hohman, T. J., Blennow, K., Zetterberg, H., and Jefferson, A. L., Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
A. G. Ording, Veres, K., Horváth-Puhó, E., M Glymour, M., Rørth, M., Henderson, V. W., and Sørensen, H. T., Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study., J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
A. G. Ording, Veres, K., Horváth-Puhó, E., M Glymour, M., Rørth, M., Henderson, V. W., and Sørensen, H. T., Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study., J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study., J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points., J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
L. Feng, Cheah, I. Kee- Mun, Ng, M. Mei- Xi, Li, J., Chan, S. Mei, Lim, S. Lin, Mahendran, R., Kua, E. - H., and Halliwell, B., The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore., J Alzheimers Dis, vol. 68, no. 1, pp. 197-203, 2019.
H. Li, Luo, X. - B., Xu, Y., and Hou, X. - Y., A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus., J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
M. Fujikura, Iwahara, N., Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Manabe, T., Matsushita, T., Suzuki, S., and Shimohama, S., CD14 and Toll-Like Receptor 4 Promote Fibrillar Aβ42 Uptake by Microglia Through A Clathrin-Mediated Pathway., J Alzheimers Dis, vol. 68, no. 1, pp. 323-337, 2019.
Y. Hatada, Hashimoto, M., Shiraishi, S., Ishikawa, T., Fukuhara, R., Yuki, S., Tanaka, H., Miyagawa, Y., Kitajima, M., Uetani, H., Tsunoda, N., Koyama, A., and Ikeda, M., Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
Y. Hatada, Hashimoto, M., Shiraishi, S., Ishikawa, T., Fukuhara, R., Yuki, S., Tanaka, H., Miyagawa, Y., Kitajima, M., Uetani, H., Tsunoda, N., Koyama, A., and Ikeda, M., Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Vuono, R., Bickerton, A., Jones, E., Fincham, R., Allinson, K., Holland, A., and Zaman, S. H., Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia., J Alzheimers Dis, vol. 69, no. 1, pp. 91-109, 2019.
R. Raha-Chowdhury, Henderson, J. W., Raha, A. Alexander, Vuono, R., Bickerton, A., Jones, E., Fincham, R., Allinson, K., Holland, A., and Zaman, S. H., Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia., J Alzheimers Dis, vol. 69, no. 1, pp. 91-109, 2019.
M. Haddad, Perrotte, M., Landri, S., Lepage, A., Fülöp, T., and Ramassamy, C., Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
O. N. Groeneveld, Moneti, C., Heinen, R., de Bresser, J., Kuijf, H. J., Exalto, L. G., Boomsma, J. M. F., L Kappelle, J., Barkhof, F., Prins, N. D., Scheltens, P., van der Flier, W. M., and Biessels, G. Jan, The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus., J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
M. Marjańska, J McCarten, R., Hodges, J. S., Hemmy, L. S., and Terpstra, M., Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy., J Alzheimers Dis, vol. 68, no. 2, pp. 559-569, 2019.
M. Marjańska, J McCarten, R., Hodges, J. S., Hemmy, L. S., and Terpstra, M., Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy., J Alzheimers Dis, vol. 68, no. 2, pp. 559-569, 2019.
J. M. J. Vonk, Rentería, M. Arce, Medina, V. M., Pericak-Vance, M. A., Byrd, G. S., Haines, J., Brickman, A. M., and Manly, J. J., Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults., J Alzheimers Dis, vol. 72, no. 2, pp. 495-506, 2019.
N. Sakae, Heckman, M. G., Vargas, E. R., Carrasquillo, M. M., Murray, M. E., Kasanuki, K., Ertekin-Taner, N., Younkin, S. G., and Dickson, D. W., Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures., J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
T. Tarumi, Rossetti, H., Thomas, B. P., Harris, T., Tseng, B. Y., Turner, M., Wang, C., German, Z., Martin-Cook, K., Stowe, A. M., Womack, K. B., Mathews, D., Kerwin, D. R., Hynan, L., Diaz-Arrastia, R., Lu, H., C Cullum, M., and Zhang, R., Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial., J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
T. Tarumi, Rossetti, H., Thomas, B. P., Harris, T., Tseng, B. Y., Turner, M., Wang, C., German, Z., Martin-Cook, K., Stowe, A. M., Womack, K. B., Mathews, D., Kerwin, D. R., Hynan, L., Diaz-Arrastia, R., Lu, H., C Cullum, M., and Zhang, R., Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial., J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
M. Hashimoto, Yamazaki, A., Ohno, A., Kimura, T., Winblad, B., and Tjernberg, L. O., A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease., J Alzheimers Dis, vol. 71, no. 4, pp. 1163-1174, 2019.
P. Oeckl, Halbgebauer, S., Anderl-Straub, S., Steinacker, P., Huss, A. M., Neugebauer, H., von Arnim, C. A. F., Diehl-Schmid, J., Grimmer, T., Kornhuber, J., Lewczuk, P., Danek, A., Ludolph, A. C., and Otto, M., Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment., J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.
P. Oeckl, Halbgebauer, S., Anderl-Straub, S., Steinacker, P., Huss, A. M., Neugebauer, H., von Arnim, C. A. F., Diehl-Schmid, J., Grimmer, T., Kornhuber, J., Lewczuk, P., Danek, A., Ludolph, A. C., and Otto, M., Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment., J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.

Pages